Source CE Certified Hyaluronic Acid Gel for Wrinkles, Lips, Contours

CE Certified Hyaluronic Acid Gel Sourcing Guide

Procurement professionals must first distinguish between products marketed for injection and those intended for external use, as the supplied data reveals conflicting usage modes for similar formulations. While some listings explicitly state "Injection Skin" and "for External Injection," others describe the product as "for External Use" with a "Puncture Instrument" mode, creating a critical compliance ambiguity that requires immediate clarification before any order is placed.

Buyers should verify the specific intended application for each SKU, noting that the core ingredient is consistently identified as Cross-Linked Hyaluronic Acid Gel with a concentration of 24mg/Ml. The observed product models range from "Fine Derm" to "Deep Subskin," suggesting different viscosities for distinct anatomical areas, yet the packaging descriptions vary between blister packs and double corrugated boxes, necessitating a strict review of the technical datasheet for every batch.

Product Scope and Observed Listing Signals

The market signals indicate a diverse range of product forms, including gel, liquid, and liquid gel states, all centered on the primary function of removing wrinkles, filling folds, and shaping facial contours. Listings frequently mention specific brand names like Reyoungel and Singfiller, with available volumes spanning from 1ml to 20ml, which implies a need for buyers to match the specific syringe volume to their clinical requirements for lip filling versus deep dermal correction.

Sourcing teams must carefully evaluate the customization options, as the data confirms that OEM services and ODM capabilities are available for branding and packaging. The presence of "Transparent" color attributes and "Pre-Filled Syringe" configurations suggests a standardized aesthetic product line, but the variation in packing descriptions, such as blister packages versus double corrugated boxes, requires verification to ensure the final product meets the specific logistical and storage needs of the target market.

Technical Specifications to Verify

Technical due diligence must focus on the cross-linked agent, which is identified as BDDE in the provided specifications, a critical factor for determining the longevity and safety profile of the dermal filler. Buyers should confirm the exact concentration of Sodium Hyaluronate Acid, as the data lists 24mg/Ml, and verify if this concentration remains consistent across the different model variants like Fine Lines or Deep Subskin to ensure predictable clinical outcomes.

The physical form and component composition require strict alignment with the intended procedure, as some entries list the form as "Gel" while others specify "Liquid Gel" or "Liquid." Procurement officers must validate that the component is indeed Cross-Linked Hyaluronic Acid and that the product model, whether labeled as Fine Derm or Deep Subskin, corresponds to the correct injection depth and tissue layer for the specific aesthetic application planned by the medical facility.

Compliance and Safety Documentation

Regulatory verification is paramount given the mixed certification data, which includes CE, ISO, and MSDS, alongside specific drug registration numbers like Zsyjxscx20100115. Buyers must ensure that the specific product batch carries the exact regulatory approval number required for the destination market, as the presence of a generic CE mark does not automatically guarantee compliance with local medical device regulations for injectable substances.

Safety documentation must explicitly address the disinfection status and the sterile nature of the pre-filled syringes, as the listings mention "Two Sterile Needles" and "Disinfection" protocols. It is essential to request the full Certificate of Analysis for each shipment to confirm that the cross-linking process using BDDE has been completed safely and that the final product meets the necessary sterility standards for injection procedures.

Cost Drivers and Commercial Terms

Pricing in this sector is highly variable, with observed ranges spanning from 6 to 150 USD, driven largely by the specific product model, volume, and the level of customization required. The MOQ range of 1 to 50 units suggests flexibility for smaller clinics but may impact unit economics for larger distributors, requiring a detailed cost-benefit analysis based on the specific volume needed for the Fine, Derm, or Deep subskin variants.

Commercial terms must clearly define the supply type, as the data indicates both OEM Service and OEM/ODM options are available, which can significantly alter the cost structure and lead times. Buyers should negotiate based on the specific packaging requirements, such as whether the product arrives in a blister package or double corrugated box, as these logistical details often influence the final landed cost and the efficiency of the supply chain.

Supplier Qualification and Quality Control

Supplier qualification should prioritize manufacturers that can demonstrate a consistent track record with the specific certifications listed, including CE, ISO, and MSDS, while also providing the specific drug registration number for the product. The origin is listed as China, so buyers must verify the supplier's ability to maintain quality control standards that align with international expectations for medical devices, particularly regarding the cross-linking process and sterility assurance.

Quality control protocols must be rigorously audited to ensure that the "Portable" nature of the product does not compromise its stability or efficacy during transit. Procurement teams should request evidence of batch testing for the HA concentration and the BDDE cross-linking agent, ensuring that every unit meets the specified standards for removing wrinkles and filling folds without introducing safety risks to the end patient.

Long-Term Procurement Checks

Establishing a long-term partnership requires regular re-verification of the product specifications, as the data shows variations in model names and packing descriptions that could indicate different production lines or formulations. Buyers should implement a schedule for periodic audits to ensure that the "Cross-Linked Hyaluronic Acid Gel" continues to meet the 24mg/Ml concentration and that the BDDE levels remain within safe limits over time.

Sourcing strategies must also account for the potential for regulatory changes, given the specific drug registration numbers and certification statuses observed in the current listings. It is advisable to maintain a relationship with the supplier that allows for rapid updates on any changes to the product standard or formulation, ensuring that the supply chain remains compliant with evolving medical device regulations in the target markets.